Efficacy of SGLT2 Inhibitors in Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis of Preclinical Studies

This systematic review and meta-analysis of nine preclinical studies demonstrates that SGLT2 inhibitors significantly improve pulmonary hemodynamics and right ventricular function in animal models of pulmonary arterial hypertension, suggesting their potential as a novel therapeutic strategy.

Qubbaj, F., Saeed, A., Younis, O. + 5 more2026-03-20📄 pharmacology and toxicology

Voltage-Gated Sodium Channel Modulation Differentially Alters ON and OFF Bipolar Cell Contributions to the Rat ERG

This study demonstrates that pharmacological modulation of voltage-gated sodium channels differentially alters ON and OFF cone bipolar cell contributions to the rat ERG b-wave, revealing distinct sodium channel-mediated mechanisms in these pathways that could inform retinal stimulation strategies for degenerative conditions.

Bellare, J., Pai, A. V., Kulkarni, Y.2026-03-19📄 pharmacology and toxicology

Polypharmacology of an Optimal Kinase Library

This study presents a comprehensive kinome-wide profiling of 192 diverse kinase inhibitors, revealing that polypharmacology is widespread and independent of regulatory approval, with many approved drugs exhibiting potent off-target effects on understudied kinases that complicate mechanism-of-action studies but offer opportunities for drug repurposing and toxicity prediction.

Mills, C. E., Hug, C., Sajeevan, K. A. + 9 more2026-03-19📄 pharmacology and toxicology

Widely circulating pyrethroid resistance mechanisms reduce the efficacy of transfluthrin and pose a risk for mosquito-borne disease control with spatial emanators

This study demonstrates that widely circulating pyrethroid resistance mechanisms, including target site mutations and P450 over-expression, significantly reduce the efficacy of transfluthrin-based spatial emanators by diminishing both irritancy and blood-feeding inhibition in mosquitoes, thereby posing a critical risk to malaria and other vector-borne disease control efforts.

Kokkas, E., Jones, J., Weetman, D. + 15 more2026-03-18📄 pharmacology and toxicology

A Novel Hollow Fiber Infection Model (HFIM) for Antiviral PK/PD studies of CMV infection.

This study validates a novel, low-cost hollow fiber infection model using hemodialyzer cartridges to simulate human ganciclovir pharmacokinetics and establish the first pharmacokinetic/pharmacodynamic targets for treating cytomegalovirus (CMV) infection, thereby enabling optimized dosing strategies and resistance management.

Sudarsono, L. M., Wenker, S. A. M., Liu, X. + 4 more2026-03-17📄 pharmacology and toxicology

Paroxetine-induced transient apoptosis with delayed neurogenesis induces brain remodeling in developing zebrafish

This study demonstrates that early paroxetine exposure in developing zebrafish induces transient apoptosis and delayed neurogenesis, leading to brain remodeling and impaired social behavior, thereby providing a biological mechanism linking prenatal antidepressant use to the pathogenesis of autism spectrum disorder.

Sato, T., Saito, K., Oyu, T. + 8 more2026-03-16📄 pharmacology and toxicology

Identification of a pharmacokinetic interaction between teicoplanin and sulfo-butyl ether-beta-cyclodextrin, an excipient in the intravenous posaconazole formulation

This study identifies a pharmacokinetic interaction where the sulfo-butyl ether-beta-cyclodextrin (SBECD) excipient in intravenous posaconazole reduces teicoplanin protein binding, leading to increased renal elimination and lower drug concentrations in hematopoietic stem cell transplant patients.

Adachi, Y., Sugimoto, M., Yamada, Y. + 19 more2026-03-13📄 pharmacology and toxicology

Red yeast rice-derived MKA ameliorates cardiac hypertrophy in hypertensive rats by inhibiting ERK1/2/c-Fos pathway

This study demonstrates that red yeast rice-derived monacolin K {beta}-hydroxy acid (MKA) ameliorates cardiac hypertrophy in spontaneously hypertensive rats by inhibiting the ERK1/2/c-Fos signaling pathway, offering a safe, multi-organ protective, and transgenerationally effective therapeutic strategy for hypertensive heart disease.

Tan, R., Yang, D., Liu, K. + 6 more2026-03-13📄 pharmacology and toxicology

Cancer-derived Extracellular Vesicles for Targeted Delivery of EGFRvIII siRNA to Glioblastoma, Comparison of siRNA Loading Methods and Efficiency

This study demonstrates that cancer-derived extracellular vesicles loaded with EGFRvIII siRNA via transfection achieve efficient in vitro knockdown and selective tumor homing in vivo, although this targeted delivery failed to induce significant tumor shrinkage despite successfully downregulating EGFRvIII expression.

Shojaei-Ghahrizjani, F., Tawil, N., Meehan, B. + 5 more2026-03-13📄 pharmacology and toxicology

Inhaled nitric oxide as a rescue therapy in rat crush syndrome: translating bench research to field application

This study demonstrates that administering inhaled nitric oxide via a portable device immediately after reperfusion significantly improves survival rates and physiological outcomes in a rat model of crush syndrome, suggesting its potential as an effective emergency intervention in disaster settings.

Murata, I., Kobayashi, J., Ishihara, S. + 1 more2026-03-12📄 pharmacology and toxicology

Circulating MicroRNAs as Potential Diagnostic Biomarkers for Heart Failure: A Systematic Review and Meta-Analysis

This systematic review and meta-analysis of 86 studies identifies a panel of 71 consistently dysregulated circulating microRNAs, with miR-21 and miR-423-5p emerging as high-quality, robust diagnostic biomarkers for heart failure, while highlighting the need for standardized protocols to address heterogeneity across species and sample types.

Sun, W., Hu, B., Li, D. + 3 more2026-03-12📄 pharmacology and toxicology

Identification of compounds that repress DUX4 expression in facioscapulohumeral muscular dystrophy

Using an AI-based screening pipeline targeting the chromatin remodeling factor BAZ1A, researchers identified compound C06 as a potent and specific repressor of pathogenic DUX4 expression in facioscapulohumeral muscular dystrophy, demonstrating its viability as a therapeutic candidate despite its ability to inhibit multiple kinases.

Chang, N., Moore, H. P., Himeda, C. L. + 4 more2026-03-11📄 pharmacology and toxicology